Clinical trial
Study of the Effect of Treatment With Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure
NCT00837655 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Effect of Treatment With Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure
- Lead sponsor
- Karolinska Institutet
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 31, 2009
- Completion date
- June 30, 2011
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, hyperphosphatemia, insulin resistance, kidney failure, chronic